- Drugs
- Tuesday, 17 Sep 2019
Aphria Inc.'s Jamaican Subsidiary, Marigold, Receives Retail Herb House Licence
Aphria Inc. announced that its subsidiary Marigold Projects Jamaica Limited ("Marigold") has received a retail Herb House license from Jamaica's Cannabis Licensing Authority ("CLA") to open its first store in Kingston, Jamaica.
Aphria, Inc. is engaged in the production and supply of medical cannabis. It operates through three reportable segments including cannabis operations, distribution operations, and business under development. The Cannabis Operations segment produces, distributes, and sells both medical and adult-use cannabis. The Distribution Operations segment are carried out through its wholly owned subsidiaries ABP, FL Group, and CC Pharma. The Distribution under Development segment includes operations in which the firm has not received final licensing or has not commenced commercial sales from operations. The company offers medical cannabis of various strains, including Kusawa, Tamaracouta, Panache, Churchill and Iroquois. The Company is also engaged in the research and development, and commercial production of cannabis oil. The company was founded by Cole Cacciavillani and John Cervini on June 22, 2011 and is headquartered in Leamington, Canada. Aphria’s subsidiaries include Pure Natures Wellness Inc. that are engaged in the production and distribution of medical marijuana, and Cannway Pharmaceuticals Ltd., which specializes in offering support services to veterans and their first responders.
Related Industry Updates
Rx Green Technologies Launches New Clean Coco Coir Products
May 05, 2020
Human Vaccine Adjuvants Market is expected to reach US$ 4,489.23 million by 2030
Jan 04, 2024
Janssen Highlights Continued Commitment to Cardiovascular & Metabolic Healthcare Solutions with Late-Breaking Data at the First Fully Virtual American College of Cardiology Scientific Session
Mar 20, 2020
Esteve acquires German proprietary, specialty, hospital-focused company Riemser and expands its presence in Europe
Jan 08, 2020
Enteral Nutrition Market is expected to reach US$ 13,204.19 million by 2030
Oct 31, 2023
Prostate Cancer Therapeutics Market is expected to grow US$ 28,425.27 million by 2030
Dec 12, 2023
Europe Small Molecule Drug Delivery Market: Industry Overview, Trends and Growth Opportunities Forecasted Till 2027
Aug 25, 2020